Smarter. Stronger. Together: Optimizing Personalized Triple-Negative Breast Cancer Care for Providers and Patients

Review latest practice-changing data and gain expert insights into the optimization and personalization of care of patients with TNBC including a Cancer Conversations webinar with discussions about the key areas of consensus and controversy in the management of TNBC an on-demand webcast an audio podcast a downloadable slideset from the live webinar and focused commentaries.

Share

Program Content

Activities

Optimizing TNBC Care
Smarter. Stronger. Together: Optimizing Personalized Triple-Negative Breast Cancer Care for Providers and Patients
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 05, 2022

Expires: December 04, 2023

No activities added yet

Activities

Sacituzumab Govitecan in TNBC
A 44-Year-Old Patient With Rapidly Progressing Metastatic TNBC Who Receives Sacituzumab Govitecan
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: November 14, 2022

Expires: November 13, 2023

FAQs: Optimal Tx of TNBC
FAQs: Optimizing Management of Patients with Triple-Negative Breast Cancer
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: March 14, 2023

Expires: March 12, 2024

Activities

Individualizing TNBC Care: Podcast Pearls
Podcast Pearls
Individualizing Care for Patients With Triple-Negative Breast Cancer
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: January 18, 2023

Expires: January 17, 2024

Treatment of TNBC
Individualizing Care for Patients With Triple-Negative Breast Cancer
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: January 18, 2023

Expires: January 17, 2024

Faculty

cover img faculity

Mark D. Pegram, MD

Leonard M. Miller School of Medicine
University of Miami
Miami, Florida

cover img faculity

Mark Pegram

Professor
Medical Oncology
Stanford University
Palo Alto, California

cover img faculity

Laura M. Spring, MD

Breast Medical Oncologist
Mass General Hospital Cancer Center
Harvard Medical School
Boston, Massachusetts

cover img faculity

Sara M. Tolaney, MD, MPH

Chief, Division of Breast Oncology
Dana-Farber Cancer Institute
Associate Professor of Medicine
Harvard Medical School
Boston, Massachusetts

cover img faculity

Sara M. Tolaney, MD, MPH

Assistant Professor of Medicine
Harvard Medical School
Associate Director
Susan F. Smith Center for Women’s Cancers
Director
Clinical Trials, Breast Oncology
Director
Breast Immunotherapy Clinical Research
Dana-Farber Cancer Institute
Boston, Massachusetts

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Gilead Sciences, Inc.

Partners

Smart Patients

ProCE Banner